Mike Krsulich

Mike Krsulich brings over 15 years of experience leading cGxP quality management activities involving quality system development and technical quality oversight to Reaction Biology. Mike has worked in collaboration with domestic and international teams including external strategic partners to successfully progress small molecule, large molecule, cell and gene therapies as well as medical device programs from pre-clinical development through to commercialization. Mike is focused on leading the quality function by developing a harmonized global quality strategy and implementing best operating practices. Prior to joining Reaction Biology, Mike was most recently Senior Director of GxP Quality Assurance at Renovacor, Inc. prior to its acquisition by Rocket Pharmaceuticals and previously Senior Director of GMP Quality Assurance at Galera Therapeutics. Earlier in his career, Mike held positions of increasing cGxP quality assurance responsibilities at Teva Pharmaceuticals, Eisai Inc., OPK Biotech, LLC., Globus Medical Inc., WuXi AppTec, Inc., and McNeil Consumer Healthcare. Mike holds a BS in Psychology from the University of Pittsburgh.